PMI Q4 Earnings Call Highlights [Yahoo! Finance]
Precigen, Inc. (PGEN)
Last precigen, inc. earnings: 3/2 04:05 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
Wednesday, March 25, 2026, update call covering fourth-quarter and full-year 2025 results. Management said the company has shifted from being primarily an R&D organization to a product revenue-generating commercial biotechnology company, driven by the launch of PAPZIMEOS as a first-line treatment for adult recurrent respiratory papillomatosis (RRP). Early commercial ramp highlighted by Q1 revenue expectation President and CEO Helen Sabzevari said PAPZIMEOS was granted early and full approval in August with a “broad label” for adult RRP, with no restriction tied to the number of prior surgeries. The company began commercial shipments in November, resulting in net product revenue of $3.4 million in Q4 2025 , according to management. ? Active ETFs Surge Past Passive, and These Are in the Lead While noting that Precigen does not plan to provide revenue guidance regularly, Sabzevari said the company expects a substantial step-up in the first full quarter of sales. Based on commerci
Show less
Read more
Impact Snapshot
Event Time:
PGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PGEN alerts
High impacting Precigen, Inc. news events
Weekly update
A roundup of the hottest topics
PGEN
News
- Discover Precigen And 2 Other Insider-Favored Growth Stocks [Yahoo! Finance]Yahoo! Finance
- Is It Too Late To Consider Precigen (PGEN) After Its 145% One Year Surge? [Yahoo! Finance]Yahoo! Finance
- Precigen (PGEN) had its price target raised by Citizens Jmp from $8.00 to $9.00. They now have a "market outperform" rating on the stock.MarketBeat
- Precigen gains after 2025 results on Papzimeos outlook [Seeking Alpha]Seeking Alpha
- Precigen (PGEN) had its price target raised by HC Wainwright from $9.00 to $10.00. They now have a "buy" rating on the stock.MarketBeat
PGEN
Earnings
- 3/25/26 - Miss
PGEN
Sec Filings
- 3/25/26 - Form 10-K
- 3/25/26 - Form 8-K
- 3/20/26 - Form 4
- PGEN's page on the SEC website